Envoy Medical (COCH) announced that the American Medical Association, AMA, Current Procedural Terminology, CPT, Editorial Panel has approved five Category III CPT codes for totally implantable active middle ear implants, AMEI, a crucial development for the Company’s already FDA-approved Esteem product. This marks the first time that there will be CPT codes for totally implantable active middle ear hearing implants like the Esteem device. With a new set of CPT codes, a path to reimbursement for the breakthrough Esteem Fully Implanted Active Middle Ear Implant, FI-AMEI, may begin to take shape.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COCH:
- Envoy Medical initiated with a Buy at Brookline
- Envoy Medical celebrates one year trading as public company
- Envoy Medical investor discusses Apple AirPods Pro 2 hearing aid announcement
- Envoy Medical awarded patent for recharge system used with implantable battery
- Envoy Medical secures lending facility of $10M